Lactobacillus paracasei endocarditis in a consumer of probiotics with advanced and severe bicuspid aortic valve stenosis complicated with diffuse left ventricular mid-layer fibrosis

Int J Cardiol. 2016 Dec 1;224:157-161. doi: 10.1016/j.ijcard.2016.09.002. Epub 2016 Sep 3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anti-Bacterial Agents / administration & dosage*
  • Aortic Valve / abnormalities*
  • Aortic Valve / diagnostic imaging
  • Aortic Valve / microbiology
  • Aortic Valve Stenosis* / complications
  • Aortic Valve Stenosis* / diagnosis
  • Aortic Valve Stenosis* / physiopathology
  • Bicuspid Aortic Valve Disease
  • Echocardiography / methods
  • Endocarditis, Bacterial* / diagnosis
  • Endocarditis, Bacterial* / etiology
  • Endocarditis, Bacterial* / microbiology
  • Endocarditis, Bacterial* / physiopathology
  • Endomyocardial Fibrosis* / diagnosis
  • Endomyocardial Fibrosis* / etiology
  • Heart Valve Diseases* / diagnostic imaging
  • Heart Valve Diseases* / microbiology
  • Heart Ventricles* / diagnostic imaging
  • Heart Ventricles* / pathology
  • Humans
  • Lactobacillus paracasei* / isolation & purification
  • Lactobacillus paracasei* / pathogenicity
  • Male
  • Probiotics / therapeutic use
  • Severity of Illness Index
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents